Trisenox Related Clinical Trials
Arsenic Trioxide With Ascorbic Acid and Melphalan for Myeloma Patients [Completed]
Velcade, Trisenox, Vitamin C and Melphalan for Myeloma Patients [Active, not recruiting]
Phase II Research Study of Arsenic Trioxide (Trisenox) in Patients With Myelodysplastic Syndrome (MDS) [Terminated]
Liposomal Doxorubicin, Vincristine, & Dexamethasone Plus Arsenic Trioxide in Untreated Symptomatic Multiple Myeloma [Suspended]
A Phase II Protocol of Arsenic Trioxide (Trisenox) in Subjects With Advanced Primary Carcinoma of the Liver [Recruiting]
Arsenic Trioxide in Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma [Active, not recruiting]
A Phase II Trial of Trisenox Plus Thalomid as Treatment in Patients With Myelodysplastic Syndrome [Terminated]
Evaluation of Disulfiram Plus Arsenic Trioxide In Patients With Metastatic Melanoma and at Least One Prior Systemic Therapy [Recruiting]
Arsenic Trioxide in Treating Women With Locally Advanced or Metastatic Breast Cancer [Active, not recruiting]
Arsenic Trioxide in Treating Patients With Metastatic Liver Cancer That Cannot Be Removed by Surgery [Active, not recruiting]
Arsenic Trioxide in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer [Active, not recruiting]
Arsenic Trioxide and Ascorbic Acid Combined With Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia [Active, not recruiting]
Arsenic Trioxide, Temozolomide, and Radiation Therapy in Treating Patients With Malignant Glioma That Has Been Removed By Surgery [Active, not recruiting]
Study of IV Decitabine, Arsenic Trioxide and Vitamin C in Patients With Myelodysplastic Syndromes [Recruiting]
Arsenic Trioxide Plus Vitamin C in Treating Patients With Recurrent or Refractory Multiple Myeloma [Completed]
Study of Low-Dose Cytarabine in Combination With Arsenic Trioxide, Compared With Low-Dose Cytarabine Alone, for the Treatment of Elderly Patients With Acute Myeloid Leukemia [Recruiting]
Arsenic Trioxide and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia [Active, not recruiting]
Arsenic Trioxide and Pamidronate in Treating Patients With Advanced Solid Tumors or Multiple Myeloma [Active, not recruiting]
Arsenic Trioxide, Thalidomide, Dexamethasone, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma [Active, not recruiting]
Single Agent Arsenic Trioxide in the Treatment of Newly Diagnosed Acute Promyelocytic Leukemia [Recruiting]
Trial of Arsenic Trioxide With Ascorbic Acid in the Treatment of Adult Non-APL Acute Myelogenous Leukemia [Recruiting]
Arsenic Trioxide and Gemtuzumab Ozogamicin in Treating Patients With Advanced Myelodysplastic Syndromes [Recruiting]
Arsenic Trioxide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma [Active, not recruiting]
Arsenic Trioxide and Cholecalciferol (Vitamin D) in Treating Patients With Myelodysplastic Syndromes [Active, not recruiting]
Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Treating Patients With Multiple Myeloma [Withdrawn]
Melphalan, Arsenic Trioxide, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma [Withdrawn]
Arsenic Trioxide and Imatinib Mesylate in Treating Patients With Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia [Completed]
Radiation Therapy, Arsenic Trioxide, and Temozolomide in Treating Patients With Newly Diagnosed High-Grade Glioma [Recruiting]
Trisenox, Ascorbic Acid and Bortezomib in Patients With Relapsed/Refractory Multiple Myeloma [Recruiting]
Tretinoin and Arsenic Trioxide With or Without Idarubicin in Treating Patients With Acute Promyelocytic Leukemia [Recruiting]
Arsenic Trioxide in Treating Patients With Recurrent Bladder or Urinary Tract Cancer [Active, not recruiting]
Arsenic Trioxide and Thalidomide in the Treatment of Refractory Multiple Myeloma [Active, not recruiting]
Arsenic Trioxide in Treating Patients With Advanced Cancer of the Esophagus or Gastroesophageal Junction [Completed]
Arsenic Trioxide and Etanercept in Treating Patients With Myelodysplastic Syndromes [Completed]
Azacitidine and Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia [Active, not recruiting]
Arsenic Trioxide, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia [Recruiting]
Pilot Trial of Arsenic + Cytarabine in Patients With Myelofibrosis [Recruiting]
Bortezomib, Arsenic Trioxide, and Melphalan in Treating Patients Undergoing an Autologous Stem Cell Transplant For Multiple Myeloma [Suspended]
Arsenic Trioxide and Radiation Therapy in Treating Young Patients With Newly Diagnosed Gliomas [Recruiting]
New Retinoid Agent Combined With Arsenic Trioxide for Untreated Acute Promyelocytic Leukemia [Not yet recruiting]
Iodine I 131 Metaiodobenzylguanidine and Arsenic Trioxide in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma [Recruiting]
Arsenic Trioxide in Treating Patients With Stage IVB or Recurrent Cervical Cancer [Completed]
Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid Tumors [Suspended]
Arsenic Trioxide in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia [Completed]
Arsenic Trioxide in Treating Patients With Relapsed or Refractory Lymphoma or Leukemia [Completed]
Arsenic Trioxide in Treating Patients With Refractory or Recurrent Acute Promyelocytic Leukemia [No longer recruiting]
Arsenic Trioxide in Treating Young Patients With Refractory Leukemia or Lymphoma [Completed]
Arsenic Trioxide in Treating Patients With Relapsed or Refractory Hodgkin's Disease [No longer recruiting]
Arsenic Trioxide in Treating Patients With Pancreatic Cancer That Has Not Responded to Gemcitabine [Completed]
Arsenic Trioxide in Treating Patients With Relapsed or Refractory Chronic Myelogenous Leukemia [Completed]
Arsenic Trioxide in Treating Patients With Refractory or Relapsed Chronic Lymphocytic Leukemia [Completed]
Arsenic Trioxide in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Previous Hormone Therapy [Completed]
Arsenic Trioxide in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Has Not Responded to Previous Treatment
Arsenic Trioxide in Treating Men With Germ Cell Cancer
Arsenic Trioxide in Treating Patients With Acute Myeloid Leukemia [Completed]
Arsenic Trioxide in Treating Patients With Metastatic Kidney Cancer
Phase I Trial of Arsenic Trioxide and Stereotactic Radiotherapy for Recurrent Malignant Glioma [Active, not recruiting]
Arsenic Trioxide With or Without Tretinoin in Treating Patients With Hematologic Cancer That Has Not Responded to Previous Therapy [Active, not recruiting]
Arsenic Trioxide in Treating Patients With Relapsed or Refractory Non- Hodgkin's Lymphoma [Completed]
Arsenic Trioxide and Dexamethasone in Treating Patients With Recurrent or Refractory Stage II or Stage III Multiple Myeloma [No longer recruiting]
Arsenic Trioxide in Treating Patients With Recurrent or Refractory Acute Leukemia, Chronic Myeloide Leukemia, Myelodysplasia, Lymphoma, or Myeloma [No longer recruiting]
Arsenic Trioxide in Treating Patients With Recurrent or Refractory Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia [No longer recruiting]
Treatment of Relapsed Promyelocytic Leukemia With Arsenic Trioxide (ATO) [Recruiting]
Arsenic Trioxide, Fluorouracil, and Leucovorin in Treating Patients With Stage IV Colorectal Cancer That Has Relapsed or Not Responded to Treatment [Recruiting]
Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Treating Patients With Chronic Idiopathic Myelofibrosis or Myelodysplastic or Myeloproliferative Disorders [Recruiting]
Arsenic Trioxide in Combination With Cytarabine in Patients With High-Risk MDS and Poor-Prognosis AML [Completed]
Arsenic Trioxide in Treating Patients With Advanced Solid Tumors [Completed]
Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes [Active, not recruiting]
Arsenic Trioxide in Treating Patients With Advanced Hematologic Cancer [Completed]
Arsenic Trioxide in Treating Patients With Multiple Myeloma [Active, not recruiting]
Azacitidine and Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes [Recruiting]
Cephalon Decitabine, Arsenic Trioxide and Ascorbic Acid for Myelodysplastic Syndrome [Recruiting]
Treatment Protocol for Relapsed Acute Promyelocytic Leukemia (APL) With Arsenic [Recruiting]
All-Trans Retinoic Acid, and Arsenic +/- Gemtuzumab and Theophylline [Recruiting]
Acute Promyelocytic Leukemia 2006 (APL) [Recruiting]
A Phase II Study of Gleevec and Arsenic Trioxide in Patients With CML Who Fail Gleevec [Completed]
Safety, Efficacy, & Pharmacokinetic Study of Tamibarotene to Treat Patients With Relapsed or Refractory APL [Recruiting]
Combination Chemotherapy in Treating Patients With Acute Promyelocytic Leukemia [Suspended]
Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Promyelocytic Leukemia [Recruiting]
Chemotherapy Plus Monoclonal Antibody in Treating Patients With Acute Promyelocytic Leukemia [No longer recruiting]
Combination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes [Recruiting]
Study of NRX 195183 Therapy for Patients With Relapsed or Refractory Acute Promyelocytic Leukemia [Recruiting]
|
